QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis

Clinical trial NCT00581997 · TERMINATED

Trial details

NCT number: NCT00581997
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Fibrosis Secondary to Systemic Sclerosis

Start date: 2007-12-01
Primary completion: 2009-04-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.